Exact Sciences Login

Exact Sciences Laboratories is dedicated to delivering the most accurate results and providing physicians and patients with world-class service. Cologuard® is an FDA-approved, noninvasive multi-target stool DNA test for colorectal cancer screening.

EpicCare Link Provider Portal Set-Up. In order for providers to order the Cologuard test via the EpicCare Link Provider Portal, you must first fill out the set-up form on CologuardTest.com.

Contact Your Customer Care Center Get answers to questions related to your screening. We are here for you! Request Your Results Request a copy of your result report

If you see this message despite using one of the browser configurations mentioned above, please contact your system administrator. *Tablets are not supported in Executive Dashboards.

Contact Exact Sciences' customer care center, HR, investor relations, general inquiries, media relations, or medical affairs.

Exact Sciences is an equal employment opportunity employer. All qualified applicants will receive consideration for employment without regard to age, color, creed, disability, gender identity, national origin, protected veteran status, race, religion, sex, sexual orientation, and any other status protected by applicable local, state or federal law.

Exact Sciences is an equal employment opportunity employer. All qualified applicants will receive consideration for employment without regard to age, color, creed, disability, gender identity, national origin, protected veteran status, race, religion, sex, sexual orientation, and any other status protected by applicable local, state or federal law.

Indication and Important Risk Information Cologuard is intended for the qualitative detection of colorectal neoplasia associated DNA markers and for the presence of occult hemoglobin in human stool. A positive result may indicate the presence of colorectal cancer (CRC) or advanced adenoma (AA) and should be followed by diagnostic colonoscopy.

Indication and Important Risk Information Cologuard is intended for the qualitative detection of colorectal neoplasia associated DNA markers and for the presence of occult hemoglobin in human stool. A positive result may indicate the presence of colorectal cancer (CRC) or advanced adenoma (AA) and should be followed by diagnostic colonoscopy.